{"date":"2025-08-06","count":50,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2025-08-06-2014-dxgxi8","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-08-06","time":"20:14:00","subject":"代重要子公司Belite Bio, Inc公告受邀參加H.C. Wainwright &Co.投資銀行舉辦之第五屆眼科線上年會(H.C. Wainwright 5thAnnual Ophthalmology Virtual Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-08-06 20:14，「代重要子公司Belite Bio, Inc公告受邀參加H.C. Wainwright &Co.投資銀行舉辦之第五屆眼科線」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-08-06-1827-1bkm0mx","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"18:27:39","subject":"公告本公司代理發言人異動","clause":"第8款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-08-06 18:27，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-08-06-1819-1tkkj4d","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"18:19:47","subject":"公告本公司114年第二季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-08-06 18:19，「公告本公司114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-08-06-1817-p67uuk","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"18:17:28","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-08-06 18:17，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2025-08-06-1816-1laykb2","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"18:16:17","subject":"公告114年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2025-08-06 18:16，「公告114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2025-08-06-1806-w2f525","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"18:06:22","subject":"公告本公司董事會通過114年度第二季合併財務報表","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2025-08-06 18:06，「公告本公司董事會通過114年度第二季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-08-06-1804-fymson","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-08-06","time":"18:04:58","subject":"公告本公司董事會決議解除本公司經理人競業禁止之限制案","clause":"第22款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-08-06 18:04，「公告本公司董事會決議解除本公司經理人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-08-06-1758-x640zg","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-08-06","time":"17:58:14","subject":"董事會通過研發主管任命案","clause":"第11款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-08-06 17:58，「董事會通過研發主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2025-08-06-1748-1ifbulk","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"17:48:21","subject":"公告本公司董事會推選副董事長","clause":"第6款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：南光（1752），2025-08-06 17:48，「公告本公司董事會推選副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2025-08-06-1745-1q33mjh","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"17:45:32","subject":"公告本公司總經理退休暨新任總經理就任案","clause":"第6款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：南光（1752），2025-08-06 17:45，「公告本公司總經理退休暨新任總經理就任案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2025-08-06-1740-xyhazt","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"17:40:43","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：南光（1752），2025-08-06 17:40，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2025-08-06-1739-1rtnmn7","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"17:39:59","subject":"公告本公司114年第2季財務報告董事會召開日期。","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2025-08-06 17:39，「公告本公司114年第2季財務報告董事會召開日期。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2025-08-06-1739-vpi78d","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"17:39:17","subject":"公告本公司「台生材愛克斯導管導引線」獲得台灣衛生福利部(TFDA)核發之外銷專用醫療器材許可證核准通知。","clause":"第53款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2025-08-06 17:39，「公告本公司「台生材愛克斯導管導引線」獲得台灣衛生福利部(TFDA)核發之外銷專用醫療器材許可證核准通知。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2025-08-06-1737-1ogcyvd","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"17:37:25","subject":"公告本公司向關係人取得不動產使用權資產","clause":"第20款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2025-08-06 17:37，「公告本公司向關係人取得不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2025-08-06-1732-kkcjm6","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"17:32:11","subject":"公告本公司114年第2季合併財務報告業經提報董事會","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2025-08-06 17:32，「公告本公司114年第2季合併財務報告業經提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2025-08-06-1729-om5dp7","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"17:29:20","subject":"公告本公司董事會決議委任第六屆薪資報酬委員會成員","clause":"第6款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2025-08-06 17:29，「公告本公司董事會決議委任第六屆薪資報酬委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-08-06-1729-140kqs7","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-08-06","time":"17:29:05","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第43款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-08-06 17:29，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2025-08-06-1727-wxikfe","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"17:27:10","subject":"本公司董事會通過114年第2季財務報告","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2025-08-06 17:27，「本公司董事會通過114年第2季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-08-06-1726-1n7vy0s","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"17:26:10","subject":"本公司提報董事會114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-08-06 17:26，「本公司提報董事會114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-08-06-1718-1vwhr84","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"17:18:16","subject":"本公司資金貸與餘額達「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款之公告標準","clause":"第23款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-08-06 17:18，「本公司資金貸與餘額達「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款之公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-08-06-1711-j330cr","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"17:11:52","subject":"公告本公司董事會通過民國114年第二季合併財務報表","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-08-06 17:11，「公告本公司董事會通過民國114年第二季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2025-08-06-1709-1o5sa57","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"17:09:44","subject":"公告本公司董事會決議辦理註銷限制員工權利新股股份，訂定減資基準日案","clause":"第11款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2025-08-06 17:09，「公告本公司董事會決議辦理註銷限制員工權利新股股份，訂定減資基準日案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2025-08-06-1704-1mnsyzo","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"17:04:24","subject":"公告本公司董事會通過114年度第二季合併財報","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2025-08-06 17:04，「公告本公司董事會通過114年度第二季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2025-08-06-1642-d7ktf8","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"16:42:03","subject":"公告本公司新任副董事長","clause":"第6款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2025-08-06 16:42，「公告本公司新任副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2025-08-06-1641-j0iylv","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"16:41:41","subject":"公告本公司訂定除權基準日及相關事宜","clause":"第14款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2025-08-06 16:41，「公告本公司訂定除權基準日及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2025-08-06-1641-xyhazt","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"16:41:20","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2025-08-06 16:41，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-08-06-1632-19ws7nb","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"16:32:01","subject":"公告本公司除息基準日","clause":"第14款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-08-06 16:32，「公告本公司除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-08-06-1622-1852nlh","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"16:22:50","subject":"公告本公司董事會通過委任永續發展委員會委員","clause":"第6款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-08-06 16:22，「公告本公司董事會通過委任永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-08-06-1621-1jsjgdy","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"16:21:55","subject":"公告本公司董事會通過委任薪酬委員會成員","clause":"第6款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-08-06 16:21，「公告本公司董事會通過委任薪酬委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-08-06-1617-npa0g0","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"16:17:56","subject":"代重要子公司神隆醫藥(常熟)有限公司公告法人監事解任","clause":"第6款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-08-06 16:17，「代重要子公司神隆醫藥(常熟)有限公司公告法人監事解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-08-06-1616-xyhazt","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"16:16:05","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-08-06 16:16，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-08-06-1614-g8sjce","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"16:14:29","subject":"本公司董事會通過114年第2季個別財務報告","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-08-06 16:14，「本公司董事會通過114年第2季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-08-06-1613-1xmtl8w","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"16:13:59","subject":"公告本公司董事會通過代理發言人、會計主管、財務主管及公司治理主管異動","clause":"第8款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-08-06 16:13，「公告本公司董事會通過代理發言人、會計主管、財務主管及公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2025-08-06-1602-1mve6xu","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"16:02:16","subject":"公告本公司董事會通過委任薪資報酬委員會委員","clause":"第6款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2025-08-06 16:02，「公告本公司董事會通過委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-08-06-1602-kmkc57","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"16:02:02","subject":"公告本公司董事會決議新增委任一席薪資報酬委員會委員","clause":"第6款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-08-06 16:02，「公告本公司董事會決議新增委任一席薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2025-08-06-1601-1lmjpi4","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"16:01:15","subject":"公告本公司113年度盈餘分配之除息基準日","clause":"第14款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2025-08-06 16:01，「公告本公司113年度盈餘分配之除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2025-08-06-1600-xyhazt","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"16:00:04","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2025-08-06 16:00，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2025-08-06-1555-1xtjtmq","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"15:55:03","subject":"公告本公司董事會通過114年第二季財務報告","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2025-08-06 15:55，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-08-06-1540-1cgm95r","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"15:40:07","subject":"公告本公司向關係人租賃取得不動產使用權資產","clause":"第20款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-08-06 15:40，「公告本公司向關係人租賃取得不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-08-06-1539-799td3","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"15:39:51","subject":"公告本公司解除財會主管競業禁止之限制","clause":"第21款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-08-06 15:39，「公告本公司解除財會主管競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-08-06-1539-12m7nlh","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"15:39:26","subject":"公告本公司解除總經理競業禁止之限制","clause":"第21款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-08-06 15:39，「公告本公司解除總經理競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-08-06-1538-176f2w1","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"15:38:40","subject":"公告本公司董事會委任總經理","clause":"第6款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-08-06 15:38，「公告本公司董事會委任總經理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-08-06-1538-xyhazt","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"15:38:23","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-08-06 15:38，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2025-08-06-1517-uxtlhs","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"15:17:34","subject":"公告本公司董事會決議除權息基準日","clause":"第14款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2025-08-06 15:17，「公告本公司董事會決議除權息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2025-08-06-1516-14rx3u9","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"15:16:50","subject":"公告本公司114年第二季個別財務報告","clause":"第31款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2025-08-06 15:16，「公告本公司114年第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-08-06-1426-1fqkmsr","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"14:26:32","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-08-06 14:26，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-08-06-1349-f088rl","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"13:49:42","subject":"公告本公司調整配股率","clause":"第14款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-08-06 13:49，「公告本公司調整配股率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-08-06-1128-1ppi0i3","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-08-06","time":"11:28:30","subject":"本公司收回已發行之限制員工權利新股辦理註銷減資變更登記完成","clause":"第36款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-08-06 11:28，「本公司收回已發行之限制員工權利新股辦理註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-08-06-1032-1fqkmsr","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-08-06","time":"10:32:49","subject":"澄清媒體報導","clause":"第26款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-08-06 10:32，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-08-06-0937-1fqkmsr","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-06","time":"09:37:47","subject":"澄清媒體報導","clause":"第26款","fact_date":"2025-08-06","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-08-06 09:37，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}